What does this research mean for the field?

Hydrocortisone demonstrates encouraging therapeutic results in the treatment of de Quervain's disease and tenosynovitis at other sites, warranting further clinical trials. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

June 25, 1955BMJOpen Access

Effects of Modified E.C.T. on the Electrocardiogram

View Full Paper

Ask AI

Bookmark

Key result

Hydrocortisone shows encouraging preliminary results for treating de Quervain's disease and tenosynovitis.

Design

Small case series

Authors

RGR. GreenCalifornia Department of Parks and Recreation AWAlisa G. WoodsClarkson University

Discussion

Member takes

Implication

Does not support routine use; hypothesis-generating for hydrocortisone in de Quervain's, needing RCTs.

Structured PICO

Population

Patients with de Quervain's disease and tenosynovitis

Intervention

Hydrocortisone

Hydrocortisone shows encouraging results in a small series of patients with de Quervain's disease and tenosynovitis.

Cite This Study

Green et al. (1955) studied this question. Hydrocortisone demonstrated encouraging results that merit further investigation for the treatment of de Quervain's disease and tenosynovitis.

synapsesocial.com/papers/6aab5f71bd3f8b92ad732672 https://doi.org/10.1136/bmj.1.4929.1503

View Full Paper

Ask AI

Bookmark

Effects of Modified E.C.T. on the Electrocardiogram

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Effects of Modified E.C.T. on the Electrocardiogram

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Also Consider